| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.99B | $1.17B | $711.6M |
| YoY Revenue Growth % | +69.7% | +65.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$877.1M | -$203.9M | $198.0M |
| Operating Margin % | -44.0% | -17.4% | 27.8% |
| Net Income (GAAP) | -$743.3M | -$172.8M | $167.8M |
| EBITDA (Normalized) | -$875.0M | -$199.9M | $223.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $66.5M | $64.9M | $161.5M |
| Capital Expenditures (CapEx) | $2.6M | $5.1M | $32.0M |
| Free Cash Flow (FCF) | $63.9M | $59.8M | $129.5M |
| FCF Margin % | 3.2% | 5.1% | 18.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -17.8% | 8.8% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $2.12B | $1.17B | $690.7M |
| Total Stockholders' Equity | -$378.8M | $209.8M | $1.42B |